Experimental agent acts against aggressive lymphoma subtype
The drug ibrutinib can provide significant anticancer responses with modest side effects in persons with diffuse large B-cell lymphomas (DLBCLs).
Diagnosis & Disease Information
Mutations in XRCC2 gene tied to breast cancer risk
Mutations in a gene called XRCC2 have been linked to breast cancer susceptibility in families with none of the currently known breast-risk genes.
New marker flags DNA repair response to platinum therapy
A new marker of DNA damage may predict which triple-negative breast cancers or serous ovarian cancers will respond to platinum-based chemotherapy.
Stress management boosts immune system in breast cancer
A stress-management program for women with breast cancer can alter tumor-promoting processes at the molecular level, according to researchers.
Opioids may spur tumor growth
Although opioid-based painkillers are a standard treatment for relieving cancer pain, they may actually contribute to disease progression.
Wayward gene found, vanquished in some East Asians with CML and NSCLC
Researchers found that a gene mutation prevents tyrosine kinase inhibitors from working in some East Asian cancer patients, and can correct this.
A second gene may predispose women to breast cancer
Scientists have discovered that the Abraxas gene may advance the mission of BRCA1 and may even act on its own to help breast cancer develop.
Genetic profile IDs leukemia patients for high-dose chemotherapy
Persons with acute myeloid leukemia who harbor specific gene mutations may have improved overall survival with higher doses of chemotherapy.
Genes identified for ovarian cancer prognosis
Validated bimodal genes can define relevant molecular subtypes of ovarian cancer.
Survival improves for youths with leukemia
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia rose from 83.7% for 1990-1994 to 90.4% for 2000-2005.
- Loading...
Loading...
Loading... 
Loading...